Alfred Altomari - Net Worth and Insider Trading
Alfred Altomari Net Worth
The estimated net worth of Alfred Altomari is at least $2 Million dollars as of 2024-11-07. Alfred Altomari is the Director of Insmed Inc and owns about 20,938 shares of Insmed Inc (INSM) stock worth over $2 Million. Alfred Altomari is the Director of Davis Select U.S. Equity ETF and owns about 12,000 shares of Davis Select U.S. Equity ETF (DUSA) stock worth over $530,760. Alfred Altomari is also the CEO of Agile Therapeutics Inc and owns about 1,287 shares of Agile Therapeutics Inc (AGRX) stock worth over $1,943. Besides these, Alfred Altomari also holds Societal CDMO Inc (SCTL) , Baudax Bio Inc (BXRXQ) . Details can be seen in Alfred Altomari's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alfred Altomari has not made any transactions after 2022-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alfred Altomari
Alfred Altomari Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alfred Altomari owns 4 companies in total, including Agile Therapeutics Inc (AGRX) , Insmed Inc (INSM) , and Baudax Bio Inc (BXRXQ) among others .
Click here to see the complete history of Alfred Altomari’s form 4 insider trades.
Insider Ownership Summary of Alfred Altomari
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGRX | Agile Therapeutics Inc | 2022-08-26 | director & Chief Executive Officer |
| INSM | Insmed Inc | 2020-12-07 | director |
| BXRXQ | Baudax Bio Inc | 2020-11-23 | director |
 | | 2016-12-15 | director |
Alfred Altomari Latest Holdings Summary
Alfred Altomari currently owns a total of 5 stocks. Among these stocks, Alfred Altomari owns 20,938 shares of Insmed Inc (INSM) as of December 7, 2020, with a value of $2 Million and a weighting of 73.75%. Alfred Altomari owns 12,000 shares of Davis Select U.S. Equity ETF (DUSA) as of August 11, 2011, with a value of $530,760 and a weighting of 26.08%. Alfred Altomari also owns 1,287 shares of Agile Therapeutics Inc (AGRX) as of August 26, 2022, with a value of $1,943 and a weighting of 0.1%. The other 2 stocks Societal CDMO Inc (SCTL) , Baudax Bio Inc (BXRXQ) have a combined weighting of 0.08% among all his current holdings.
Latest Holdings of Alfred Altomari
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INSM | Insmed Inc | 2020-12-07 | 20,938 | 71.69 | 1,501,045 |
| DUSA | Davis Select U.S. Equity ETF | 2011-08-11 | 12,000 | 44.23 | 530,760 |
| AGRX | Agile Therapeutics Inc | 2022-08-26 | 1,287 | 1.51 | 1,943 |
| SCTL | Societal CDMO Inc | 2016-12-15 | 1,500 | 1.10 | 1,650 |
| BXRXQ | Baudax Bio Inc | 2020-11-23 | 44 | 0.00 | 0 |
Holding Weightings of Alfred Altomari
Alfred Altomari Form 4 Trading Tracker
According to the SEC Form 4 filings, Alfred Altomari has made a total of 1 transactions in Insmed Inc (INSM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Insmed Inc is the sale of 20,000 shares on December 7, 2020, which brought Alfred Altomari around $791,400.
According to the SEC Form 4 filings, Alfred Altomari has made a total of 0 transactions in Davis Select U.S. Equity ETF (DUSA) over the past 5 years. The most-recent trade in Davis Select U.S. Equity ETF is the acquisition of 2,000 shares on August 11, 2011, which cost Alfred Altomari around $8,120.
According to the SEC Form 4 filings, Alfred Altomari has made a total of 5 transactions in Agile Therapeutics Inc (AGRX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Agile Therapeutics Inc is the acquisition of 1,000 shares on August 26, 2022, which cost Alfred Altomari around $22,500.
More details on Alfred Altomari's insider transactions can be found in the Insider Trading History of Alfred Altomari table.Insider Trading History of Alfred Altomari
- 1
Alfred Altomari Trading Performance
GuruFocus tracks the stock performance after each of Alfred Altomari's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alfred Altomari is 2.5%. GuruFocus also compares Alfred Altomari's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alfred Altomari within 3 months outperforms 7 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alfred Altomari's insider trading performs compared to the benchmark.
Performance of Alfred Altomari
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.13 | | | | | |
| Relative Return to S&P 500(%) | -1.98 | | | | | |
Alfred Altomari Ownership Network
Ownership Network List of Alfred Altomari
Ownership Network Relation of Alfred Altomari
Alfred Altomari Owned Company Details
What does Agile Therapeutics Inc do?
Who are the key executives at Agile Therapeutics Inc?
Alfred Altomari is the director & Chief Executive Officer of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Agile Therapeutics Inc (AGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agile Therapeutics Inc Insider Transactions
Alfred Altomari Mailing Address
Above is the net worth, insider trading, and ownership report for Alfred Altomari. You might contact Alfred Altomari via mailing address: C/o Agile Therapeutics, Inc., 101 Poor Farm Road, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
